Tilray Inc (NASDAQ:TLRY – Get Free Report)’s share price was down 4% during mid-day trading on Friday . The company traded as low as $1.66 and last traded at $1.66. Approximately 3,753,590 shares traded hands during mid-day trading, a decline of 86% from the average daily volume of 27,195,645 shares. The stock had previously closed at $1.73.
Analyst Ratings Changes
A number of research firms have issued reports on TLRY. Canaccord Genuity Group cut their price objective on shares of Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Alliance Global Partners increased their price target on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research report on Friday, April 5th. Finally, CIBC dropped their price objective on Tilray from $2.25 to $2.00 and set a “neutral” rating for the company in a report on Wednesday, April 10th.
Check Out Our Latest Stock Report on TLRY
Tilray Price Performance
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the business. Cetera Advisors LLC grew its holdings in shares of Tilray by 209.5% during the 1st quarter. Cetera Advisors LLC now owns 115,665 shares of the company’s stock valued at $286,000 after purchasing an additional 78,292 shares during the last quarter. Virtu Financial LLC bought a new stake in shares of Tilray during the first quarter worth $586,000. Tidal Investments LLC increased its holdings in shares of Tilray by 36,687.0% during the first quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock worth $26,373,000 after buying an additional 10,648,403 shares in the last quarter. California State Teachers Retirement System lifted its stake in shares of Tilray by 4.4% in the 1st quarter. California State Teachers Retirement System now owns 678,990 shares of the company’s stock valued at $1,677,000 after acquiring an additional 28,586 shares during the last quarter. Finally, Bayesian Capital Management LP boosted its holdings in shares of Tilray by 193.0% during the 1st quarter. Bayesian Capital Management LP now owns 54,800 shares of the company’s stock valued at $135,000 after acquiring an additional 36,100 shares in the last quarter. Institutional investors and hedge funds own 9.35% of the company’s stock.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
See Also
- Five stocks we like better than Tilray
- Why Invest in 5G? How to Invest in 5G Stocks
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Ride Out The Recession With These Dividend Kings
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Canadian Penny Stocks: Can They Make You Rich?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.